Report Detail

Request for Sample of this report

Chemical & Material Global Perindopril Erbumine API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4638781
    • |
  • 24 October, 2025
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Perindopril Erbumine API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Perindopril Erbumine is the tert-butylamine salt of perindopril, the ethyl ester of a non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Upon hydrolysis, perindopril erbumine is converted to its active form perindoprilat, inhibiting ACE and the conversion of angiotensin I to angiotensin II; consequently, angiotensin II-mediated vasoconstriction and angiotensin II-stimulated aldosterone secretion from the adrenal cortex are inhibited and diuresis and natriuresis ensue.
This report is a detailed and comprehensive analysis for global Perindopril Erbumine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Perindopril Erbumine API market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Perindopril Erbumine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Perindopril Erbumine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Perindopril Erbumine API market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Perindopril Erbumine API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Perindopril Erbumine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Piramal Enterprises Limited, Cipla, Lupin Ltd, Glenmark Pharmaceuticals, ARCH PHARMALABS LIMITED, Zhejiang Huahai Pharmaceutial. Co., Ltd., Aarti Industries Ltd., Qiushi Pharm, Menovo Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Perindopril Erbumine API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Perindopril Erbumine Tablets
Others
Major players covered
Piramal Enterprises Limited
Cipla
Lupin Ltd
Glenmark Pharmaceuticals
ARCH PHARMALABS LIMITED
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Aarti Industries Ltd.
Qiushi Pharm
Menovo Pharm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Perindopril Erbumine API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Perindopril Erbumine API, with price, sales quantity, revenue, and global market share of Perindopril Erbumine API from 2020 to 2025.
Chapter 3, the Perindopril Erbumine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Perindopril Erbumine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Perindopril Erbumine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Perindopril Erbumine API.
Chapter 14 and 15, to describe Perindopril Erbumine API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Perindopril Erbumine API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Perindopril Erbumine API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Perindopril Erbumine Tablets
    • 1.4.3 Others
  • 1.5 Global Perindopril Erbumine API Market Size & Forecast
    • 1.5.1 Global Perindopril Erbumine API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Perindopril Erbumine API Sales Quantity (2020-2031)
    • 1.5.3 Global Perindopril Erbumine API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Piramal Enterprises Limited
    • 2.1.1 Piramal Enterprises Limited Details
    • 2.1.2 Piramal Enterprises Limited Major Business
    • 2.1.3 Piramal Enterprises Limited Perindopril Erbumine API Product and Services
    • 2.1.4 Piramal Enterprises Limited Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Piramal Enterprises Limited Recent Developments/Updates
  • 2.2 Cipla
    • 2.2.1 Cipla Details
    • 2.2.2 Cipla Major Business
    • 2.2.3 Cipla Perindopril Erbumine API Product and Services
    • 2.2.4 Cipla Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Cipla Recent Developments/Updates
  • 2.3 Lupin Ltd
    • 2.3.1 Lupin Ltd Details
    • 2.3.2 Lupin Ltd Major Business
    • 2.3.3 Lupin Ltd Perindopril Erbumine API Product and Services
    • 2.3.4 Lupin Ltd Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Lupin Ltd Recent Developments/Updates
  • 2.4 Glenmark Pharmaceuticals
    • 2.4.1 Glenmark Pharmaceuticals Details
    • 2.4.2 Glenmark Pharmaceuticals Major Business
    • 2.4.3 Glenmark Pharmaceuticals Perindopril Erbumine API Product and Services
    • 2.4.4 Glenmark Pharmaceuticals Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.5 ARCH PHARMALABS LIMITED
    • 2.5.1 ARCH PHARMALABS LIMITED Details
    • 2.5.2 ARCH PHARMALABS LIMITED Major Business
    • 2.5.3 ARCH PHARMALABS LIMITED Perindopril Erbumine API Product and Services
    • 2.5.4 ARCH PHARMALABS LIMITED Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 ARCH PHARMALABS LIMITED Recent Developments/Updates
  • 2.6 Zhejiang Huahai Pharmaceutial. Co., Ltd.
    • 2.6.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Details
    • 2.6.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Major Business
    • 2.6.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Perindopril Erbumine API Product and Services
    • 2.6.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
  • 2.7 Aarti Industries Ltd.
    • 2.7.1 Aarti Industries Ltd. Details
    • 2.7.2 Aarti Industries Ltd. Major Business
    • 2.7.3 Aarti Industries Ltd. Perindopril Erbumine API Product and Services
    • 2.7.4 Aarti Industries Ltd. Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Aarti Industries Ltd. Recent Developments/Updates
  • 2.8 Qiushi Pharm
    • 2.8.1 Qiushi Pharm Details
    • 2.8.2 Qiushi Pharm Major Business
    • 2.8.3 Qiushi Pharm Perindopril Erbumine API Product and Services
    • 2.8.4 Qiushi Pharm Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Qiushi Pharm Recent Developments/Updates
  • 2.9 Menovo Pharm
    • 2.9.1 Menovo Pharm Details
    • 2.9.2 Menovo Pharm Major Business
    • 2.9.3 Menovo Pharm Perindopril Erbumine API Product and Services
    • 2.9.4 Menovo Pharm Perindopril Erbumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Menovo Pharm Recent Developments/Updates

3 Competitive Environment: Perindopril Erbumine API by Manufacturer

  • 3.1 Global Perindopril Erbumine API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Perindopril Erbumine API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Perindopril Erbumine API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Perindopril Erbumine API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Perindopril Erbumine API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Perindopril Erbumine API Manufacturer Market Share in 2024
  • 3.5 Perindopril Erbumine API Market: Overall Company Footprint Analysis
    • 3.5.1 Perindopril Erbumine API Market: Region Footprint
    • 3.5.2 Perindopril Erbumine API Market: Company Product Type Footprint
    • 3.5.3 Perindopril Erbumine API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Perindopril Erbumine API Market Size by Region
    • 4.1.1 Global Perindopril Erbumine API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Perindopril Erbumine API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Perindopril Erbumine API Average Price by Region (2020-2031)
  • 4.2 North America Perindopril Erbumine API Consumption Value (2020-2031)
  • 4.3 Europe Perindopril Erbumine API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Perindopril Erbumine API Consumption Value (2020-2031)
  • 4.5 South America Perindopril Erbumine API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Perindopril Erbumine API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Perindopril Erbumine API Sales Quantity by Type (2020-2031)
  • 5.2 Global Perindopril Erbumine API Consumption Value by Type (2020-2031)
  • 5.3 Global Perindopril Erbumine API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Perindopril Erbumine API Sales Quantity by Application (2020-2031)
  • 6.2 Global Perindopril Erbumine API Consumption Value by Application (2020-2031)
  • 6.3 Global Perindopril Erbumine API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Perindopril Erbumine API Sales Quantity by Type (2020-2031)
  • 7.2 North America Perindopril Erbumine API Sales Quantity by Application (2020-2031)
  • 7.3 North America Perindopril Erbumine API Market Size by Country
    • 7.3.1 North America Perindopril Erbumine API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Perindopril Erbumine API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Perindopril Erbumine API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Perindopril Erbumine API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Perindopril Erbumine API Market Size by Country
    • 8.3.1 Europe Perindopril Erbumine API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Perindopril Erbumine API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Perindopril Erbumine API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Perindopril Erbumine API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Perindopril Erbumine API Market Size by Region
    • 9.3.1 Asia-Pacific Perindopril Erbumine API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Perindopril Erbumine API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Perindopril Erbumine API Sales Quantity by Type (2020-2031)
  • 10.2 South America Perindopril Erbumine API Sales Quantity by Application (2020-2031)
  • 10.3 South America Perindopril Erbumine API Market Size by Country
    • 10.3.1 South America Perindopril Erbumine API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Perindopril Erbumine API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Perindopril Erbumine API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Perindopril Erbumine API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Perindopril Erbumine API Market Size by Country
    • 11.3.1 Middle East & Africa Perindopril Erbumine API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Perindopril Erbumine API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Perindopril Erbumine API Market Drivers
  • 12.2 Perindopril Erbumine API Market Restraints
  • 12.3 Perindopril Erbumine API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Perindopril Erbumine API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Perindopril Erbumine API
  • 13.3 Perindopril Erbumine API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Perindopril Erbumine API Typical Distributors
  • 14.3 Perindopril Erbumine API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Perindopril Erbumine API. Industry analysis & Market Report on Perindopril Erbumine API is a syndicated market report, published as Global Perindopril Erbumine API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Perindopril Erbumine API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo